Abstract:Problem: According to the guidelines, acute vulvovaginal candidosis (VVC) may be treated vaginally, through a combination of vaginal treatment and cream for the vulva or orally. However, there is a lack of investigations into whether combined treatment for the vagina and vulva achieves better results than vaginal treatment alone. Method: In 1999, 160 patients with vulvovaginal candidosis from ten German gynaecological practices were included in a study and treated on a randomised basis with three 200 mg clotrimazol vaginal suppositories = clotrimazol 2 % cream (verum n = 79) or + placebo (active-ingredient-free cream base n = 79). The examinations took place before treatment (T1), six to eight days following the end of treatment (T2) and approximately four weeks following the end of treatment (T3). In addition to demographic data, the clinical findings of each investigation were documented in a standardised way and a native preparation and a fungal culture were taken. The doctor and patient evaluated the healing process and tolerance. The main efficacy variables were the pre/post difference scores for extravaginal redness. Results: On T1, there was no difference between the two groups. By T2, there was a significant difference in the extent of extravaginal redness between the verum and the placebo groups (p = 0.0002), as well as in the subgroup of the per-protocol analysis (verum 64, placebo 70 patients, p = 0.0015). Genital itching or burning had entirely disappeared in 51 % and 56 % of patients respectively in the verum group and in only 30 % and 45 % of patients in the placebo group on T2 (p = 0.0181). There was no difference in intravaginal redness on T1 and T2 in either group. The overall assessment by the doctor went accordingly (p = 0.0004). On T1, the extravaginal fungal culture was positive in 75 women in the verum group and in 76 women in the placebo group. On T2, however, this was positive in 51.9 % (verum) and 73.1 % (placebo) of cases, and a positive culture was evinced in the vagina in 6 vs. 8 women (7.5 vs. 10.1 %, p = 0.3802). The local tolerance in both groups was 70 % very good, and 29 vs. 27 % good. After four weeks (T3), 16 out of 23 patients in the verum group and only 8 out of 21 in the placebo group had negative extravaginal fungal cultures. Discussion: There is a lack of studies into the issue of whether vaginal treatment or combined vulvovaginal treatment of acute VVC would be more advantageous. However, there are two studies that support the significant results of this paper that when it comes to acute VVC, the combination of three 200 mg clotrimazol vaginal suppositories with clotrimazol cream 2 % is better than with vaginal suppositories alone.

Comparative Study of the Therapeutic Effect of Nigella Sativa Vaginal Suppository against Clotrimazole Vaginal Cream among Women with Candida Albicans Infection

Chamomile Extract versus Clotrimazole Vaginal Cream in Treatment of Vulvovaginal Candidiasis: A Randomized Double-Blind Control Trial

[A Multicenter, Randomized, Open and Positive Parallel Controlled Clinical Study of Clotrimazole Vaginal Expansion Suppository and Vaginal Tablet in the Treatment of Mild and Moderate Vulvovaginal Candidiasis].

The efficacy of complementary treatment with marshmallow (Althaea officinalis L.) on vulvovaginal candidiasis: A randomized double-blinded controlled clinical trial

Efficacy and safety of the combination nifuratel-nystatin and clindamycin-clotrimazole, in the treatment of bacterial vaginosis. Randomized controlled clinical trial

The Efficacy and Safety of Clotrimazole Vaginal Tablet Vs. Oral Fluconazole in Treating Severe Vulvovaginal Candidiasis.

Three-Day Combination Treatment for Vulvovaginal Candidosis with 200 mg Clotrimazol Vaginal Suppositories and Clotrimazol Cream for the Vulva is Significantly Better than Treatment with Vaginal Suppositories Alone - an Earlier, Multi-Centre, Placebo-Controlled Double Blind Study

Comparative evaluation of fluconazole and clotrimazole in treatment of oral candidiasis

Efficacy And Safety of Nifuratel-Nystatin in The Treatment of Mixed Vaginitis, in Pregnant Women From Quindío, 2013-2017. Randomized Clinical Trial

An Efficient Herbal Approach for Treating Fungal Infection in Cervical Cancer Patients by Developing and Optimizing a Vaginal Suppository

Effect of Clindamycin Phosphate Vaginal Effervescent Tablets in the Treatment of Bacterial Vaginosis

Effect of Cymbopogon olivieri-based herbal vaginal product on bacterial vaginosis

A Randomized Clinical Trial of the Efficacy and Safety of Terconazole Vaginal Suppository Versus Oral Fluconazole for Treating Severe Vulvovaginal Candidiasis.

The effect of Henna (Lawsonia inermis) vaginal suppository combined with antibiotic therapy in the treatment of cervicitis: An RCT

Effectiveness of combined use of sodium bicarbonate sitz bath prescription and vaginal nystatin suppository in the treatment of patients with fungal vaginitis

Miconazole Nitrate Vaginal Suppository 1,200 Mg Versus Oral Fluconazole 150 Mg in Treating Severe Vulvovaginal Candidiasis

Improved Treatment of Vulvovaginal Candidiasis with Clotrimazole Plus Probiotic Lacidophilin Vaginal Capsules: A Prospective, Real-World Study.

Comparing the Therapy of Otomycosis Using Clotrimazole with Iodine Tincture: A Clinical Trial

Observation of the Comprehensive Efficacy of Ozone Combined with Clotrimazole in the Treatment of Fungal Vaginitis

A Clinical Study on the Efficacy of Zinc Oxide Ointment Combined with 1％ Bifonazole Cream in the Treatment of Vulva Vagina Candida Disease

Terbinafine Versus Itraconazole and Fluconazole in the Treatment of Vulvovaginal Candidiasis